|
Volumn 9, Issue 8, 2008, Pages 823-826
|
Reflecting on a quarter century of HIV research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
ANTIRETROVIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
LENTIVIRUS VECTOR;
MICROBICIDE;
NEUTRALIZING ANTIBODY;
POXVIRUS VECTOR;
SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;
VIRUS PROTEIN;
VIRUS VECTOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIBODY RESPONSE;
ANTIGEN PRESENTATION;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORRELATION ANALYSIS;
DRUG DESIGN;
DRUG EFFICACY;
DRUG TARGETING;
GENETIC VARIABILITY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMORAL IMMUNITY;
IMMUNOPATHOGENESIS;
INFECTION CONTROL;
MEDICAL RESEARCH;
MOLECULAR MECHANICS;
NONHUMAN;
OXIDATIVE STRESS;
PANDEMIC;
PRIORITY JOURNAL;
RETROVIRUS INFECTION;
SIMIAN IMMUNODEFICIENCY VIRUS;
VACCINE PRODUCTION;
VIRUS CELL INTERACTION;
VIRUS INHIBITION;
VIRUS ISOLATION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
HISTORY, 20TH CENTURY;
HIV;
HUMANS;
RESEARCH;
|
EID: 47849129248
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni0808-823 Document Type: Conference Paper |
Times cited : (6)
|
References (26)
|